262 related articles for article (PubMed ID: 16169146)
1. Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.
Hoerndli F; David DC; Götz J
Prog Neurobiol; 2005 Jun; 76(3):169-88. PubMed ID: 16169146
[TBL] [Abstract][Full Text] [Related]
2. Functional Genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology.
David DC; Hoerndli F; Götz J
Prog Neurobiol; 2005 Jun; 76(3):153-68. PubMed ID: 16168556
[TBL] [Abstract][Full Text] [Related]
3. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
4. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
5. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
Rockenstein E; Crews L; Masliah E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
[TBL] [Abstract][Full Text] [Related]
6. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs).
Limviphuvadh V; Tanaka S; Goto S; Ueda K; Kanehisa M
Bioinformatics; 2007 Aug; 23(16):2129-38. PubMed ID: 17553855
[TBL] [Abstract][Full Text] [Related]
7. Clinical proteomics in neurodegenerative disorders.
Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
[TBL] [Abstract][Full Text] [Related]
8. Protein expression overlap: more important than which proteins change in expression?
Zabel C; Andreew A; Mao L; Hartl D
Expert Rev Proteomics; 2008 Apr; 5(2):187-205. PubMed ID: 18466051
[TBL] [Abstract][Full Text] [Related]
9. BrainProfileDB - a platform for integration of functional genomics data.
Schuchhardt J; Glintschert A; Hartl D; Irmler M; Beckers J; Stephan C; Marcus K; Klose J; Meyer HE; Malik A
Proteomics; 2008 Mar; 8(6):1162-4. PubMed ID: 18283666
[TBL] [Abstract][Full Text] [Related]
10. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking.
Zabel C; Sagi D; Kaindl AM; Steireif N; Kläre Y; Mao L; Peters H; Wacker MA; Kleene R; Klose J
J Proteome Res; 2006 Aug; 5(8):1948-58. PubMed ID: 16889417
[TBL] [Abstract][Full Text] [Related]
12. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
13. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
[TBL] [Abstract][Full Text] [Related]
14. Use of proteomics for the identification of novel drug targets in brain diseases.
Morón JA; Devi LA
J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
[TBL] [Abstract][Full Text] [Related]
15. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
Cedazo-Minguez A; Winblad B
Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
[TBL] [Abstract][Full Text] [Related]
17. A proteomic approach to assess intraneuronal inclusions associated with neurodegenerative disorders.
Kawaja MD
Curr Opin Mol Ther; 2005 Dec; 7(6):565-8. PubMed ID: 16370379
[TBL] [Abstract][Full Text] [Related]
18. Genomics and proteomics in process development: opportunities and challenges.
Gupta P; Lee KH
Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
[TBL] [Abstract][Full Text] [Related]
19. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?
Gitler AD
Neurosignals; 2008; 16(1):52-62. PubMed ID: 18097160
[TBL] [Abstract][Full Text] [Related]
20. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
